W2G
W2G Latest News:
Advancing Medical Therapy & Innovation
W2G
-
1 in 4 will suffer from Mental Illness
-
1 in 5 will suffer from Depression
-
1 in 5 will suffer from Addiction
It’s Time To Change The Way We Look At Medicine…
Medical Thinking Redesigned
Organic Cannabis +
Psilocybin Cultivation
We believe wellness starts with a standardized organic growth plan. By combining our expertise in organic cultivation technology, SWITCH proprietary genetics and our experienced genetic team, Way2Grow Biopharma is able to grow the highest quality, terpene rich, consistent organic medical cannabis.
Tissue Culture Lab
In collaboration with SWITCH Biotech, we customize medical-grade organic strains in a completely sterile production environment while reducing disease, pests, and pathogens. Our small batch approach focuses on cultivar specific environments to apply a refining, stabilizing, and purifying methodology to customize cultivars for specific medical needs.
Cannabis + Psilocybin Extraction
W2G received a Standard Cannabis Cultivation License toward the end of 2020. At W2G we focus on isolating the THC, CBD, Terpenes and Cannabinoids from the cannabis flower to give our medical patients the richest organic medical extracts available.
Science & Innovation
It is believed that some psychedelics such as psilocybin mushrooms, may help re-focus old behaviour patterns and build new and healthier ones as seen from the creation of new neural pathways. By standardizing growth plans and extraction techniques, we are developing more consistent standards used in the production and extraction of psilocybin mushrooms for medical use.
Medical Sales + Global Distribution
W2G is working on strong strategic global partnerships to promote safe and responsible production and distribution of Cannabis and Psychedelic-Based Therapeutics.
Cannabis products are available in Canada at